Home / Resources / The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery
The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery

Trialtrove curated 9,959 Phase I–III clinical trials investigating at least one drug with a disclosed 2023 start, returning growth of 9.4%, a remarkable recovery from the previous year’s decline.

Discover more by downloading the White Paper.

PDF previews of the Annual Clinical Trials Roundup 2024 Edition white paper available for download.
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you.




Your download should open in a new window. You can also manually download by clicking the button below.
Related products
Surfacing insights for a successful clinical trial
Trialtrove
臨床試験の戦略、設計、実施のための頼りになる情報リソース
Building a data driven site and investigator selection model
Sitetrove
グローバルな臨床試験の治験責任医師と治験実施施設の情報を提供する、業界をリードするスイート
Citeline subscriber exploring the diversity feasibility using Global Patient Insights.
Global Patient Insights
Enabling sponsors to optimize investigator selection and hit diversity goals faster

Related resources

Annual Completed Clinical Trials Report Banner
MAY 22, 2024
Whitepaper
Clinical

Annual Completed Clinical Trials Report

Key insights and results from our annual review of trends in clinical trials completed in 2023, based on Trialtrove data

Exploring Clinical Trial Delays_resource-card-thumbnail
NOV 28, 2023
Article
Clinical

Exploring Clinical Trial Delays

We analyzed data from trials completed during the pandemic to identify trials whose primary completion dates were pushed back by more than six months.

3D model of a RNA strand.
JUL 30, 2024
Report
商業化支援サービス

Q2 2024 Gene, Cell, + RNA Therapy Landscape Report

In this report, by Citeline and the American Society of Gene & Cell Therapy (ASGCT), new approvals in Q2 2024 were focused on the RNA landscape.

View all